Intimation of In-Principle Approval from BSE Limited under Jeena sikho Employees Stock Option Scheme, 2024 (ESOS 2024)

Date: 23rd September 2026 To, To, Manager - Listing Compliance Head – Listing Operations National Stock Exchange of India Corporate Relationship Limited, Exchange Plaza. C-1, Department, Block G, BSE Limited Bandra Kurla Complex, Bandra Phiroze Jeejeebhoy Towers, (E), Dalal Street, Mumbai 400001 Mumbai - 400 051 SCRIP Code: 544476 SYMBOL: JSLL Subject: Intimation of In-principle approval received from BSE Limited for listing of up to a maximum of 6,50,000 Equity Shares of Rs. 2/-each of Jeena Sikho Lifecare Limited to be issued under Jeena Sikho Employees Stock Option Scheme, 2024 (“ESOS 2024”). Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“SEBI Listing Regulations”), we wish to inform you that BSE Limited (“BSE”) has granted in- principle approval to the Company for listing upto a maximum of 6,50,000 Equity Shares of Rs. 2/- each under the “Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024” (“ESOS 2024”). The Company had earlier received in-principle approval from National Stock Exchange of India Limited (“NSE”) vide letter Ref. No. NSE/LIST/40419 dated 14th March, 2024, in respect of the Equity Shares proposed to be issued pursuant to exercise of Options under ESOS 2024, at a time when the Equity Shares of the Company were listed only on NSE. Subsequently, upon listing of the Equity Shares of the Company on BSE, the Company made the requisite application to BSE for grant of in-principle approval. Accordingly, BSE vide its letter Ref. No. DCS/ESOP/IP/RD/239/2026-27 dated 22nd September, 2026, has granted in-principle approval for listing of up to a maximum of 6,50,000 Equity Shares of face value of ₹2/- each, proposed to be issued pursuant to exercise of Options under ESOS 2024. The Company has accordingly obtained the requisite in-principle approvals from both NSE and BSE in respect of the Equity Shares proposed to be issued pursuant to exercise of Options under ESOS 2024. It may be noted that pursuant to the sub-division (stock split) of the Equity Shares of the Company from face value of ₹10/- each to face value of ₹2/- each, the original 1,30,000 Equity Shares approved under ESOS 2024 stand adjusted to 6,50,000 Equity Shares of face value of ₹2/- each. A copy of the in-principle approval letter received from BSE is enclosed herewith for your information and records. The said information will also be uploaded on the website of the Company at www.jeenasikho.com. You are requested to kindly take the above information on record. Thanking you, Yours faithfully, For Jeena Sikho Lifecare Limited Manish Grover Managing Director DIN: 07557886 Place: Zirakpur, Punjab Date: 23.09.2026 Encl.: A/A